ASB Consultores’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-6,241
Closed -$497K 294
2023
Q4
$497K Buy
6,241
+501
+9% +$37.7K 0.17% 49
2023
Q3
$408K Hold
5,740
0.16% 61
2023
Q2
$442K Hold
5,740
0.21% 91
2023
Q1
$431K Buy
+5,740
New +$427K 0.17% 90
2022
Q2
Sell
-5,083
Closed -$385K 188
2022
Q1
$385K Buy
5,083
+426
+9% +$33.7K 0.16% 115
2021
Q4
$397K Buy
+4,657
New +$364K 0.2% 102

Other funds holding CL

ASB Consultores's CL Position: Q1 2024 in Review

ASB Consultores sold out of Colgate-Palmolive (CL) in Q1 2024, closing a stake of 6,241 shares — an estimated $497K sold.

ASB Consultores first reported a position in CL in Q4 2021 and held it in 6 quarters. The position peaked at $497K in Q4 2023. 1,765 funds tracked by Wall St. Rank hold CL as of Q1 2024.

  • ASB Consultores reported no remaining Colgate-Palmolive position as of Q1 2024 after selling out during the quarter.
  • ASB Consultores sold 6,241 Colgate-Palmolive shares in Q1 2024, an estimated $497K.
  • ASB Consultores first reported a position in Colgate-Palmolive in Q4 2021 and held it in 6 quarters.
  • ASB Consultores's Colgate-Palmolive position peaked at $497K in Q4 2023.
  • 1,765 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2024.

Based on ASB Consultores's 13F filing for Q1 2024, filed 14 May 2024.